Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.

Walter Robert John TaylorSaorin KimSim KhengSinoun MuthPety TorEva ChristophelMavuto MukakaAlexandra KerleguerLucio LuzzattoJ Kevin BairdDidier Ménard

Published in: PLoS neglected tropical diseases (2021)

The trial was registered (ACTRN12613000003774) with the Australia New Zealand Clinical trials (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=363399&isReview=true).

Keyphrases

clinical trial
phase iii
phase ii
study protocol
open label
plasmodium falciparum
stem cells
cell therapy